Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021145355 - PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA, PREVENTING MYOPIA, AND/OR SUPPRESSING PROGRESSION OF MYOPIA

Publication Number WO/2021/145355
Publication Date 22.07.2021
International Application No. PCT/JP2021/000952
International Filing Date 14.01.2021
IPC
A61K 31/444 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
444containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
A61K 9/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
06Ointments; Bases therefor
A61K 9/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61K 9/10 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
A61P 27/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
06Antiglaucoma agents or miotics
A61P 27/10 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
10for accommodation disorders, e.g. myopia
Applicants
  • 参天製薬株式会社 SANTEN PHARMACEUTICAL CO., LTD. [JP]/[JP]
Inventors
  • 稲葉 隆明 INABA, Takaaki
  • 柴垣 圭一 SHIBAGAKI, Keiichi
  • 松岡 功 MATSUOKA, Isao
  • 本田 弘平 HONDA, Kohei
Agents
  • 山尾 憲人 YAMAO, Norihito
  • 水原 正弘 MIZUHARA, Masahiro
Priority Data
2020-00464915.01.2020JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA, PREVENTING MYOPIA, AND/OR SUPPRESSING PROGRESSION OF MYOPIA
(FR) COMPOSITION PHARMACEUTIQUE DESTINÉE AU TRAITEMENT, À LA PRÉVENTION ET/OU À L'INHIBITION DE LA PROGRESSION DE LA MYOPIE
(JA) 近視の治療、近視の予防および/または近視の進行抑制のための医薬組成物
Abstract
(EN)
The present invention provides a pharmaceutical composition for treating myopia, preventing myopia, and/or suppressing progression of myopia, the pharmaceutical composition containing omidenepag or an ester thereof, or a salt of these, as an active ingredient.
(FR)
L'invention fournit une composition pharmaceutique destinée au traitement, à la prévention et/ou à l'inhibition de la progression de la myopie qui contient, en tant que principe actif, soit un omidenepag ou un ester de celui-ci, soit un sel de ceux-ci.
(JA)
本発明は、有効成分としてオミデネパグもしくはそのエステルまたはそれらの塩を含む、近視の治療、近視の予防および/または近視の進行抑制のための医薬組成物を提供する。
Latest bibliographic data on file with the International Bureau